@failedLyndonLaRouchite @DeanBaker13 @merz @jgordon i don’t think anyone is arguing pharma work should all be done by direct govt employees on the gs pay scale. if you did do that, some costs would go up and others would go down, but @merz concerns about institutional knowledge might be hard to address. 1/

@failedLyndonLaRouchite @DeanBaker13 @merz @jgordon there are lots of pharma reform ideas (lots just from @DeanBaker13), but even when the idea is “let the state fund the work and own the product”, the state can finance start-up labs and let operators of those labs allocate resources, just as private investors now do. how the state then incentivizes high-social-return work, under what form of competition if any, becomes a question to address. /fin